| abstract |
The present invention provides a compound of formula I: □ and pharmaceutically acceptable salts thereof, wherein the substituents are as disclosed in the specification. These compounds, as well as pharmaceutical compositions containing them, are useful for the treatment or prevention of mGluR5 mediated disorders such as acute and/or chronic neurological disorders, cognitive and memory deficits, and acute and chronic pain. |